1407 / 1481
CTV L2-L1: INDICATIONS
–
No or inadequate lymphadenectomy (L)
RT L4-L3-L2-L1
–
Bulky nodal disease
–
SN (+) (Macrometastases) without lymphadenectomy
AMAROS Trial (EORTC)
(Adjuvant Management of the Axilla Radiotherapy of
Surgery) is comparing L vs axillary RT with SN (+).
RT L4-L3-L2-L1
(Micrometastases: no RT)
AMAROS
Donker 2014 Lancet Oncol
Including 4800 patients demonstrated that axillary RT is as effective as axillary
surgery with less morbidity at 5 year follow-up.